Swiss pharma suspected of delaying generic competition

by
Swissinfo
My articles My siteAbout meMy videosMy books
Follow on:TwitterFacebookGoogle +

Switzerland is home to a thriving pharmaceutical industry. (Keystone) - Click to enlarge

The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed.

The FDA slammed the development of techniques designed to complicate or even prevent developers of generic drugs from accessing sufficient quantities of original preparations to be able to do comparative studies essential to any application for approval.

The authority said it has received more than 150 complaints over the alleged misuse of FDA programmes or agreements between pharmaceutical companies and distributors.

The FDA noted that it had not investigated these allegations.

About Swissinfo

SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.

My articlesMy siteAbout meMy books
Follow on:TwitterFacebookGoogle +